Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction von Lynch, Maeve, Ahern, Tomas, Sweeney, Cheryl M., Malara, Anna, Tobin, Anne‐Marie, O'Shea, Donal, Kirby, Brian

Volltext

PA21 A rare case of diffuse infantile fibromatosis von Goh, Alicia, Lynch, Maeve

Volltext

Urticated plaques in a child von Tierney, Emma, Lynch, Maeve

Volltext

A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders von Finnegan, Paula, Ahmad, Kashif, Sadlier, Muriel, Lynch, Maeve

Volltext

To stay or not to stay? von Maeve, Lynch, Duncan, Ribbons

Volltext

Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature von James, Edward, Waldron-Lynch, Maeve G, Saif, Muhammad Wasif

Volltext

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis von Lynch, Maeve, Roche, Lisa, Horgan, Mary, Ahmad, Kashif, Hackett, Caitriona, Ramsay, Bart

Volltext

Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and... von Schneeweiss, Andreas, Chia, Stephen, Hickish, Tamas, Harvey, Vernon, Eniu, Alexandru, Waldron-Lynch, Maeve, Eng-Wong, Jennifer, Kirk, Sarah, Cortés, Javier

Volltext

44171 A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders von Finnegan, Paula, Ahmad, Kashif, Sadlier, Muriel, Lynch, Maeve

Volltext

POSTER ABSTRACTSP01 Our experience with outpatient initiation of propranolol in the treatment of complicated infantile haemangiomas von Finnegan, Paula, Rafferty, Siobhán, Byrne, Berbie, O’Shaughnessy, Ashling, Lynch, Maeve

Volltext

Product configuration marks: the shape of things to come von Lynch, Maeve

Volltext

545 - Prevalence of moderate and severe atopic dermatitis in Ireland: a cross-sectional, real-world study of a secondary care population von Gough, Oisín Shane, McEvoy, Fiona, O’Connell, Michael, Lynch, Maeve, Kirby, Brian, Murphy, Michelle

Volltext

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer von Wolf, Jürgen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J.M, Tan, Daniel S.W, Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R, de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail, Heist, Rebecca S

Volltext

A blistering eruption of the head and neck in an 18‐year‐old von Timoney, Irene, Porter, Emma, Leonard, Niamh, Uddin, Aleem, Lynch, Maeve

Volltext

P83 Biologic and Janus kinase inhibitor therapy outcomes for severe psoriasis in trisomy 21 von O’Connor, Cathal, Byrne, Berbie, Roche, Darren, O’Connell, Garret, O’Connell, Michael, Murphy, Michelle, Bourke, John, Lynch, Maeve, Bennett, Mary

Volltext

Frontmind: A Phase III, Multicenter, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk D... von Vitolo, Umberto, Nowakowski, Grzegorz S., Burke, John M., Fox, Christopher P., Trneny, Marek, Chiappella, Annalisa, Waldron-Lynch, Maeve, Wagner, Steve, Pachori, Alok, Lenz, Georg

Volltext

First-Mind: Final Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly... von Nowakowski, Grzegorz S., Duell, Johannes, Kopeckova, Katerina, Trneny, Marek, Pott, Christiane, Khouja, Mouhamad, Burke, John M., Waldron-Lynch, Maeve, Wagner, Steve, Mukhopadhyay, Amitava, Blair, Derek, Belada, David

Volltext

frontMIND: A phase III, randomized, double-blind study of tafasitamab + lenalidomide + R-CHOP versus R-CHOP alone for newly diagnosed high-intermediate and high-risk diffuse large... von Vitolo, Umberto, Nowakowski, Grzegorz S., Burke, John M., Fox, Christopher P., Trneny, Marek, Chiappella, Annalisa, Waldron-Lynch, Maeve, Hadar, Nira, Pachori, Alok, Lenz, Georg

Volltext

Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients... von Belada, David, Kopeckova, Katerina, Bergua Burgues, Juan Miguel, Stevens, Don A., Nowakowski, Grzegorz S., Waldron-Lynch, Maeve, Hadar, Nira, Weirather, Johannes, Lässig, Charlotte, Blair, Derek, Dreyling, Martin H.

Volltext

Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study von Belada, David, Kopeckova, Katerina, Bergua Burgues, Juan Miguel, Stevens, Don, André, Marc, Persona, Ernesto Perez, Pichler, Petra, Staber, Philipp B., Trneny, Marek, Duell, Johannes, Waldron-Lynch, Maeve, Wagner, Steve, Mukhopadhyay, Amitava, Dirnberger-Hertweck, Maren, Burke, John M., Nowakowski, Grzegorz S.

Volltext